Posted by Michael Wonder on 23 Feb 2021
Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands
23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of an anti-epilepsy drug now at the centre of a coronial inquest.
On Monday, Chief Coroner Deborah Marshall opened the second part of the inquiry into the deaths of six New Zealanders who died while taking Logem, a generic form of the anti-convulsant drug lamotrigine.
